Amgen (AMGN) Gross Profit (2009 - 2026)

Amgen has reported Gross Profit for 18 years, with the latest figure at $7.2 billion in Q2 2026.

• On a quarterly basis, Gross Profit rose 17.43% year-over-year to $7.2 billion in Q2 2026; TTM through Jun 2026 was $26.5 billion, a 17.61% increase from a year earlier, with the FY2025 full-year figure at $24.7 billion, up 20.17% from the prior year.
• Gross Profit was $7.2 billion for Q2 2026 at Amgen, up from $5.9 billion in the prior quarter.
• The five-year high for Gross Profit was $7.2 billion in Q2 2026, with the low at -$1.3 billion in Q4 2022.
• Average Gross Profit over 5 years is $5.1 billion, with a median of $5.2 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Profit tumbled 125.12% in 2022, then jumped 494.72% in 2023.
• Over 5 years, Gross Profit stood at -$1.3 billion in 2022, then surged by 494.72% to $5.1 billion in 2023, then climbed by 17.51% to $6.0 billion in 2024, then increased by 15.33% to $6.9 billion in 2025, then gained by 5.12% to $7.2 billion in 2026.
• The last three Gross Profit figures came in at $7.2 billion (Q2 2026), $5.9 billion (Q1 2026), and $6.9 billion (Q4 2025), per Business Quant data.